2179 — Jiangsu Recbio Technology Co Cashflow Statement
0.000.00%
- HK$4.30bn
- HK$4.02bn
Annual cashflow statement for Jiangsu Recbio Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -138 | -179 | -658 | -736 | -572 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 63.5 | 32 | 181 | -88.1 | -4.62 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -68.2 | 64.3 | -18.7 | 203 | -125 |
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -139 | -70.3 | -473 | -580 | -638 |
Capital Expenditures | -79 | -171 | -238 | -308 | -224 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -267 | -87.9 | 307 | -69.9 | 234 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -346 | -259 | 68.7 | -378 | 9.42 |
Financing Cash Flow Items | -11.6 | 0 | 20.8 | -2.84 | -10.4 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 490 | 680 | 1,229 | 839 | 275 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 5.89 | 349 | 817 | -3.47 | -334 |